Risks and Benefits of Low Molecular-Weight Heparin and Target-Specific Oral Anticoagulant Use for Thromboprophylaxis in Medically Ill Patients
Crossref DOI link: https://doi.org/10.1007/s40256-015-0122-7
Published Online: 2015-05-09
Published Print: 2015-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hale, Genevieve
Brenner, Michael
Text and Data Mining valid from 2015-05-09